BFAM vs TSLA

BFAM exhibits a mixed financial profile with a weak Piotroski F-Score of 4/9 indicating marginal financial health, and no available Altman Z-Score limits distress risk assessment. Despite strong recent earnings growth (YoY EPS +45.7%) and solid revenue momentum (11.6% growth), the company faces significant liquidity concerns with a current ratio of 0.54 and quick ratio of 0.43, suggesting near-term solvency risks. Valuation is stretched relative to Graham’s defensive standard ($44.17 vs current $93.43), though growth investors may justify the premium given robust earnings progression and analyst target of $127.33. Insider selling activity and bearish technical trend counterbalance strong profitability metrics like ROE of 14.19% and improving margins.

Tesla's deterministic health is marginally stable with a Piotroski F-Score of 4/9, but the valuation is fundamentally decoupled from financial performance. The stock trades at a massive premium to its Graham Number ($23.07) and Intrinsic Value ($7.56), while exhibiting negative revenue growth (-3.10%) and a severe collapse in earnings growth (-60.60%). With zero earnings beats in the last four quarters and bearish insider activity, the current price is supported by sentiment rather than data.